Warner Chilcott to limit DTC, rely more on reps

Share this article:
Warner Chilcott said it would “make much more limited use of DTC in support of our existing brands,” relying instead on reps to drive market share gains. In a Q2 results statement, the company said advertising and promotion expenses were down $12.1 million, or 54% for the quarter, compared to Q2 2007, mainly on a reduction in DTC. The firm continues to air TV ads for its Loestrin 24. 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.

Painkiller maker Acura gets NIH grant

The $300,000 grant will go towards an abuse-deterrent technology.

Biologics have higher psoriatic arthritis adherence

A study of psoriatic arthritis patients found greater adherence among patients whose initial treatment was a biologic, compared to those who started with a non-biologic treatment.